EUVIMEDEUVIMED entdecken
Multizentrische StudieLeitlinieOpen Access · CC BY-NC-ND 4.0

Clinical practice guideline‐inconsistent chemotherapy‐induced vomiting prophylaxis in pediatric cancer patients in community settings: A Children's Oncology Group study

Aaron J Sugalski, Allison C Grimes, Michelle M Nuño, Subhash Ramakrishnan, Melissa P Beauchemin iD, Paula D Robinson, Nancy Santesso, Alexandra M Walsh iD, Andrea R Wrightson, Lolie C Yu, Susan K Parsons, Lillian Sung und 1 weitere

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.31295 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Aaron J Sugalski und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Texas Health Science Center San Antonio, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Vomiting, Neoplasms, Antiemetics, Practice Guidelines as Topic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Canada Research Chair in Pediatric Oncology Supportive Care, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to determine the proportion of patients receiving clinical practice guideline (CPG)‐inconsistent care related to chemotherapy‐induced vomiting (CIV) prophylaxis, and to describe the association between CPG‐inconsistent care and site size. The association between delivery of CPG‐inconsistent care and patient outcomes (CIV control, admission prolongation, and unplanned healthcare visits) was also described.

Methods

This was a retrospective study conducted at Children's Oncology Group (COG) National Cancer Institute Community Oncology Research Program (NCORP) sites. Eligible patients received highly (HEC) or moderately emetogenic chemotherapy (MEC) as inpatients from January 2014 through December 2015, and were previously enrolled in a COG study. The COG generated a patient list from which patients were randomly selected for chart review by participating sites. A central panel adjudicated CIV prophylaxis received as CPG‐consistent or ‐inconsistent.

Results

Twenty‐four sites participated. Over half of patients received CPG‐inconsistent CIV prophylaxis (HEC: 59/112, 52.6%; MEC: 119/215, 55.3%). The most common reasons for CPG‐inconsistency were shortened duration of antiemetic administration or omission of dexamethasone. Site size was not found to be associated with CPG‐inconsistent care delivery (HEC: adjusted odds ratio [OR]: 0.96, 95% confidence interval [CI]: 0.76–1.23; MEC: adjusted OR: 1.07; 95% CI: 0.92–1.24). Additionally, there was no statistically significant association between receipt of CPG‐inconsistent care and patient outcomes.

Conclusions

Patients receiving MEC or HEC often received CPG‐inconsistent CIV prophylaxis. Site size was not associated with receipt of CPG‐inconsistent care. Future studies should evaluate strategies to improve CIV control among pediatric oncology patients including those aimed at improving CPG adherence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VomitingNeoplasmsAntiemeticsPractice Guidelines as TopicHumansRetrospective StudiesChildFemaleMaleChild, PreschoolAdolescentAntineoplastic AgentsInfantGuideline AdherenceFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

cancer care deliverychemotherapy‐induced vomitingclinical practice guidelinesupportive care

Substanzen

AntiemeticsAntineoplastic Agents

Autor:innen und Institutionen

  • University of Texas Health Science Center San Antonio, San Antonio, Texas, USA.
  • Children's Oncology Group, Monrovia, California, USA.
  • Department of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA.
  • Columbia University Irving Medical Center, New York, New York, USA.
  • Pediatric Oncology Group of Ontario, Toronto, Ontario, Canada.
  • Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.

ORCID-Profile: Melissa P Beauchemin, Alexandra M Walsh, L Lee Dupuis

Förderung

  • NCI NIH HHS
  • Canada Research Chair in Pediatric Oncology Supportive Care
  • NIH HHS
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Sugalski, A. J., Grimes, A. C., Nuño, M. M., Ramakrishnan, S., Beauchemin, M. P., Robinson, P. D., Santesso, N., Walsh, A. M., Wrightson, A. R., Yu, L. C., Parsons, S. K., Sung, L., & Dupuis, L. L. (2024). Clinical practice guideline‐inconsistent chemotherapy‐induced vomiting prophylaxis in pediatric cancer patients in community settings: A Children's Oncology Group study. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31295

Vancouver

Sugalski AJ, Grimes AC, Nuño MM, Ramakrishnan S, Beauchemin MP, Robinson PD, et al. Clinical practice guideline‐inconsistent chemotherapy‐induced vomiting prophylaxis in pediatric cancer patients in community settings: A Children's Oncology Group study. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31295

BibTeX
@article{Sugalski2024,
  author = {Sugalski, Aaron J and Grimes, Allison C and Nuño, Michelle M and Ramakrishnan, Subhash and Beauchemin, Melissa P and Robinson, Paula D and Santesso, Nancy and Walsh, Alexandra M and Wrightson, Andrea R and Yu, Lolie C and Parsons, Susan K and Sung, Lillian and Dupuis, L Lee},
  title = {Clinical practice guideline‐inconsistent chemotherapy‐induced vomiting prophylaxis in pediatric cancer patients in community settings: A Children's Oncology Group study},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.31295}
}
Kostenlos starten →